SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
108In the latest annual report, the letter to the shareholder's by Dr. Santi sttuck-8/26/2002
107J Pharmacol Exp Ther 2002 Sep;302(3):1278-85 Genetically engineered analogs ofscaram(o)uche-8/26/2002
106>>HAYWARD, Calif.--(BUSINESS WIRE)--Aug. 20, 2002--Kosan Biosciences Incortuck-8/20/2002
105just parking drugs A compound produced by the bacterium Streptomyces globispdalroi-8/19/2002
104Interesting find. <i>cytotoxicity ... comparable to epothilone D </i&gBiomaven-7/31/2002
103J Nat Prod 2002 Jul 26;65(7):1061-4 A New Cytotoxic Epothilone from Modified Pscaram(o)uche-7/30/2002
102Tuesday July 30, 7:30 am Eastern Time Press Release SOURCE: Kosan Biosciences Koscaram(o)uche-7/30/2002
1012002 - [7/19] - [Kosan takes on giants with cancer drug] Published: Friday, JulJohn McCarthy-7/23/2002
100Appl Environ Microbiol 2002 Jul;68(7):3287-92 Process and Metabolic Strategies scaram(o)uche-7/22/2002
99Tuesday July 16, 7:32 am Eastern Time Press Release SOURCE: Kosan Biosciences Koscaram(o)uche-7/16/2002
98somebody beat me to the concept........... Message 17730383 (since I started escaram(o)uche-7/12/2002
97J Pharmacol Exp Ther 2002 Jul;302(1):320-7 Blockade of human cardiac potassiumscaram(o)uche-7/12/2002
96Circulation 2002 Jun 18;105(24):2830-5 Pharmacological rescue of human K(+) chscaram(o)uche-7/12/2002
95wilder JnJ is more than a little mindful, with the benefit of learning from othdalroi-7/12/2002
94fda.gov <i>Recently, approvals of non-cardiac drugs with a documented effkeokalani'nui-7/12/2002
93Thanks. On my way.keokalani'nui-7/12/2002
92<i>The revised date for the meeting was April 26 2001, at which the Anti-Iscaram(o)uche-7/12/2002
91dunno..... the "approvable" letter for telithromycin has been out thscaram(o)uche-7/12/2002
90Sorry. ABT 2q PR. biz.yahoo.com See the q&a at the end.keokalani'nui-7/12/2002
89telithromycin? I don't know. What was the source of that excerpt? That isscaram(o)uche-7/12/2002
88Can anyone clue me in to what they mean by rival products; or more importantly ikeokalani'nui-7/12/2002
87>> bet it's the same group that is selling DDDP << and TLRKscaram(o)uche-7/9/2002
86104K block. bet it's the same group that is selling DDDP. Everyone see gooscaram(o)uche-7/9/2002
85HAYWARD, Calif.--(BW HealthWire)--July 9, 2002--Kosan Biosciences Incorporated (nigel bates-7/9/2002
84Deleted, but I had you beat by four minutes, Nigel. Leaving in three hours. Chtuck-7/9/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News